MTOR and cancer: FNBP1 was recently found to affect tumor survival, invasion, and metastasis through FAK/PI3K/AKT/mammalian target of rapamycin (mTOR) signaling [67], drawing connection between altered levels of cellular activity seen in both development and cancer.